Latest news articles

Added 1 day ago Drug news

Results of Phase III ARCTIC trial of durvalumab plus tremelimumab for NSCLC.- AstraZeneca

AstraZeneca and MedImmune, its global biologics research and development arm, announced high-level results from the Phase III ARCTIC trial in...

Added 1 day ago Drug news

Keytruda + Alimta + carboplatin refiled with EMA for metastatic nonsquamous NSCLC.- Merck Inc.

Merck Inc announced that following validation by the European Medicines Agency (EMA), the centralized review process has begun for the...

Added 6 days ago Drug news

FDA approves Tagrisso for first line treatment of NSCLC with epidermal growth factor receptor (EGFR) mutations.- AstraZeneca.

AstraZeneca announced that the FDA has approved Tagrisso (osimertinib) for the 1st-line treatment of patients with metastatic non-small cell lung...

Search all news articles for Cancer of bronchus or lung
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Transplantation

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Oral Anticoagulation Reversal

Oral Anticoagulation Reversal

Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.

Load more

Guidelines

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

These updated guidelines on early and locally advanced non-small-cell lung cancer focus on treatment recommendations including follow-up and survivorship.

Added 4 years ago

Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines

Dyspnoea is described as difficult or laboured breathing and is a frequent symptom in advanced cancer patients, with the highest prevalence in lung cancer. Dyspnoea has been demonstrated to be one of the most distressing...

Added 2 years ago

British Thoracic Society guidelines for the investigation and management of pulmonary nodules

The detection of pulmonary nodules is common. In populations undergoing CTscreening and at high risk of lung cancer, nodules are detected in 20–50% of individuals, depending on the size of the cut-off point for reporting a nodule.

Added 2 years ago

Search all guidelines for Cancer of bronchus or lung
 

Journal articles

The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis.

Background: Alectinib is a second-generation anaplastic lymphoma kinase (ALK) inhibitor approved by the US Food and Drug Administration to treat crizotinib-refractory non-small cell lung cancer.

Added 6 days ago

Bevacizumab in the treatment of NSCLC: patient selection and perspectives.

This review outlines the current state-of-the-art on bev use in advanced NSCLC. It also describes patient selection and future perspectives on this antiangiogenic agent.

Added 2 months ago

Patterns of elective lobectomy for lung cancer.

Background: Lobectomy is the recommended treatment for early-stage lung cancer. Little is known about variations of access to health service areas and hospital types for lobectomy overall and according to specific surgical...

Added 4 months ago

Search all journal articles for Cancer of bronchus or lung
 

Clinical trials

Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer

The incidence rate of ground-glass opacity (GGO) has been increasing these years. A great number of retrospective studies suggested that sublobar resection was better for some GGO patients.

Added 5 months ago

A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy (OAK)

This global, multicenter, open-label, randomized, controlled study will evaluate the efficacy and safety of atezolizumab (an anti-programmed death−ligand 1 [anti-PD-L1] antibody) compared with docetaxel...

Added 6 months ago

Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer (OREX-IA)

The purpose of this study is to determine the outcome of participants with clinical stage IA NSCLC treated by 3 types of surgical resection (wide wedge resection, segmentectomy, or lobectomy) according to the institutional decision-making algorithm

Added 5 months ago

Search all clinical trials for Cancer of bronchus or lung
 
Alex Keen

Alex studied Biological Sciences at university before joining EPG Health in January 2017, where he works as a digital content manager and editor.

In his spare time, Alex enjoys relaxing with a cool pint in the company of good friends. 

ELCC 2018 ‒ Roundup of this year’s conference

At the recent ELCC, held from 11‒14 April 2018, several hundred abstracts were presented detailing the latest cutting-edge research in lung cancer treatment and care. Brief summaries of some of the key abstracts are found here.

CME

Carcinoma of unknown primary origin: diagnosis and management: putting NICE guidelines into practice

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90

Non-small cell lung cancer: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
2
Registration required
1
Subscription fee
0

Lung cancer: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0
Search all CME for Cancer of bronchus or lung